vs
Healthpeak Properties（DOC）与英特格（ENTG）财务数据对比。点击上方公司名可切换其他公司
英特格的季度营收约是Healthpeak Properties的1.1倍（$823.9M vs $719.4M），Healthpeak Properties净利率更高（73.2% vs 6.0%，领先67.2%），Healthpeak Properties同比增速更快（3.1% vs -3.1%），Healthpeak Properties自由现金流更多（$357.0M vs $134.0M），过去两年Healthpeak Properties的营收复合增速更高（8.9% vs 3.4%）
Healthpeak Properties是美国医疗地产领域的房地产投资信托基金，核心投资范畴覆盖老年住宅、生命科学相关物业及医疗办公楼三类资产。公司2007年于马里兰州组建，总部设在科罗拉多州丹佛市，在尔湾、纳什维尔、旧金山均设有办事处，截至2019年12月31日共持有617处物业的权益。
英特格是面向半导体及其他高科技行业的材料供应商，全球员工约8000人，总部位于美国马萨诸塞州比勒里卡。公司在全球多国及地区布局生产、客户服务与研发设施，覆盖美国、加拿大、中国、德国、以色列、日本、马来西亚、新加坡、韩国、中国台湾等地。
DOC vs ENTG — 直观对比
营收规模更大
ENTG
是对方的1.1倍
$719.4M
营收增速更快
DOC
高出6.1%
-3.1%
净利率更高
DOC
高出67.2%
6.0%
自由现金流更多
DOC
多$223.0M
$134.0M
两年增速更快
DOC
近两年复合增速
3.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $719.4M | $823.9M |
| 净利润 | $114.0M | $49.4M |
| 毛利率 | — | 43.8% |
| 营业利润率 | 17.4% | 12.7% |
| 净利率 | 73.2% | 6.0% |
| 营收同比 | 3.1% | -3.1% |
| 净利润同比 | 2406.4% | -51.7% |
| 每股收益（稀释后） | $0.16 | $0.33 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收DOCENTG
| Q4 25 | $719.4M | $823.9M | ||
| Q3 25 | $705.9M | $807.1M | ||
| Q2 25 | $694.3M | $792.4M | ||
| Q1 25 | $702.9M | $773.2M | ||
| Q4 24 | $698.0M | $849.8M | ||
| Q3 24 | $700.4M | $807.7M | ||
| Q2 24 | $695.5M | $812.7M | ||
| Q1 24 | $606.6M | $771.0M |
净利润DOCENTG
| Q4 25 | $114.0M | $49.4M | ||
| Q3 25 | $-117.1M | $70.5M | ||
| Q2 25 | $31.7M | $52.8M | ||
| Q1 25 | $42.8M | $62.9M | ||
| Q4 24 | $4.5M | $102.2M | ||
| Q3 24 | $85.9M | $77.6M | ||
| Q2 24 | $146.0M | $67.7M | ||
| Q1 24 | $6.7M | $45.3M |
毛利率DOCENTG
| Q4 25 | — | 43.8% | ||
| Q3 25 | 58.6% | 43.5% | ||
| Q2 25 | 60.2% | 44.4% | ||
| Q1 25 | 61.1% | 46.1% | ||
| Q4 24 | 60.3% | 45.6% | ||
| Q3 24 | 60.0% | 46.0% | ||
| Q2 24 | 60.6% | 46.2% | ||
| Q1 24 | 59.8% | 45.6% |
营业利润率DOCENTG
| Q4 25 | 17.4% | 12.7% | ||
| Q3 25 | 9.2% | 15.2% | ||
| Q2 25 | 5.7% | 13.4% | ||
| Q1 25 | 7.7% | 15.8% | ||
| Q4 24 | -2.2% | 17.6% | ||
| Q3 24 | 14.1% | 16.9% | ||
| Q2 24 | 22.3% | 16.0% | ||
| Q1 24 | 3.7% | 15.3% |
净利率DOCENTG
| Q4 25 | 73.2% | 6.0% | ||
| Q3 25 | -16.6% | 8.7% | ||
| Q2 25 | 4.6% | 6.7% | ||
| Q1 25 | 6.1% | 8.1% | ||
| Q4 24 | 0.7% | 12.0% | ||
| Q3 24 | 12.3% | 9.6% | ||
| Q2 24 | 21.0% | 8.3% | ||
| Q1 24 | 1.1% | 5.9% |
每股收益（稀释后）DOCENTG
| Q4 25 | $0.16 | $0.33 | ||
| Q3 25 | $-0.17 | $0.46 | ||
| Q2 25 | $0.05 | $0.35 | ||
| Q1 25 | $0.06 | $0.41 | ||
| Q4 24 | $0.02 | $0.67 | ||
| Q3 24 | $0.12 | $0.51 | ||
| Q2 24 | $0.21 | $0.45 | ||
| Q1 24 | $0.01 | $0.30 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $467.5M | $360.4M |
| 总债务越低越好 | $9.8B | $3.7B |
| 股东权益账面价值 | $7.5B | $4.0B |
| 总资产 | $20.3B | $8.4B |
| 负债/权益比越低杠杆越低 | 1.31× | 0.94× |
8季度趋势，按日历期对齐
现金及短期投资DOCENTG
| Q4 25 | $467.5M | $360.4M | ||
| Q3 25 | $91.0M | $399.8M | ||
| Q2 25 | $89.4M | $376.8M | ||
| Q1 25 | $70.6M | $340.9M | ||
| Q4 24 | $119.8M | $329.2M | ||
| Q3 24 | $180.4M | $432.1M | ||
| Q2 24 | $106.9M | $320.0M | ||
| Q1 24 | $101.8M | $340.7M |
总债务DOCENTG
| Q4 25 | $9.8B | $3.7B | ||
| Q3 25 | $9.1B | $3.8B | ||
| Q2 25 | $9.0B | $4.0B | ||
| Q1 25 | $8.9B | $4.0B | ||
| Q4 24 | $8.7B | $4.0B | ||
| Q3 24 | $8.6B | $4.1B | ||
| Q2 24 | $8.6B | $4.1B | ||
| Q1 24 | $8.8B | $4.2B |
股东权益DOCENTG
| Q4 25 | $7.5B | $4.0B | ||
| Q3 25 | $7.6B | $3.9B | ||
| Q2 25 | $7.9B | $3.8B | ||
| Q1 25 | $8.2B | $3.7B | ||
| Q4 24 | $8.4B | $3.7B | ||
| Q3 24 | $8.6B | $3.6B | ||
| Q2 24 | $8.8B | $3.5B | ||
| Q1 24 | $8.9B | $3.4B |
总资产DOCENTG
| Q4 25 | $20.3B | $8.4B | ||
| Q3 25 | $19.6B | $8.4B | ||
| Q2 25 | $19.8B | $8.4B | ||
| Q1 25 | $19.8B | $8.4B | ||
| Q4 24 | $19.9B | $8.4B | ||
| Q3 24 | $20.0B | $8.5B | ||
| Q2 24 | $20.2B | $8.3B | ||
| Q1 24 | $20.5B | $8.4B |
负债/权益比DOCENTG
| Q4 25 | 1.31× | 0.94× | ||
| Q3 25 | 1.20× | 0.99× | ||
| Q2 25 | 1.14× | 1.05× | ||
| Q1 25 | 1.08× | 1.06× | ||
| Q4 24 | 1.04× | 1.08× | ||
| Q3 24 | 1.00× | 1.15× | ||
| Q2 24 | 0.98× | 1.18× | ||
| Q1 24 | 0.99× | 1.22× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.3B | $192.0M |
| 自由现金流经营现金流 - 资本支出 | $357.0M | $134.0M |
| 自由现金流率自由现金流/营收 | 49.6% | 16.3% |
| 资本支出强度资本支出/营收 | 124.4% | 7.0% |
| 现金转化率经营现金流/净利润 | 10.99× | 3.89× |
| 过去12个月自由现金流最近4个季度 | — | $396.2M |
8季度趋势，按日历期对齐
经营现金流DOCENTG
| Q4 25 | $1.3B | $192.0M | ||
| Q3 25 | $315.0M | $249.5M | ||
| Q2 25 | $363.5M | $113.5M | ||
| Q1 25 | $279.4M | $140.4M | ||
| Q4 24 | $1.1B | $176.1M | ||
| Q3 24 | $318.2M | $197.2M | ||
| Q2 24 | $316.2M | $111.2M | ||
| Q1 24 | $152.6M | $147.2M |
自由现金流DOCENTG
| Q4 25 | $357.0M | $134.0M | ||
| Q3 25 | — | $182.8M | ||
| Q2 25 | — | $47.0M | ||
| Q1 25 | — | $32.4M | ||
| Q4 24 | $333.7M | $68.6M | ||
| Q3 24 | — | $115.0M | ||
| Q2 24 | — | $51.9M | ||
| Q1 24 | — | $80.6M |
自由现金流率DOCENTG
| Q4 25 | 49.6% | 16.3% | ||
| Q3 25 | — | 22.6% | ||
| Q2 25 | — | 5.9% | ||
| Q1 25 | — | 4.2% | ||
| Q4 24 | 47.8% | 8.1% | ||
| Q3 24 | — | 14.2% | ||
| Q2 24 | — | 6.4% | ||
| Q1 24 | — | 10.4% |
资本支出强度DOCENTG
| Q4 25 | 124.4% | 7.0% | ||
| Q3 25 | — | 8.3% | ||
| Q2 25 | — | 8.4% | ||
| Q1 25 | — | 14.0% | ||
| Q4 24 | 105.6% | 12.7% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | — | 7.3% | ||
| Q1 24 | — | 8.6% |
现金转化率DOCENTG
| Q4 25 | 10.99× | 3.89× | ||
| Q3 25 | — | 3.54× | ||
| Q2 25 | 11.48× | 2.15× | ||
| Q1 25 | 6.52× | 2.23× | ||
| Q4 24 | 235.43× | 1.72× | ||
| Q3 24 | 3.71× | 2.54× | ||
| Q2 24 | 2.17× | 1.64× | ||
| Q1 24 | 22.85× | 3.25× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
DOC
暂无分部数据
ENTG
| Fabs | $516.3M | 63% |
| Equipment And Engineering | $121.8M | 15% |
| Chemical And Materials | $83.8M | 10% |
| Other | $61.7M | 7% |
| Non Semi | $40.3M | 5% |
